A novel approach for modifying tumor cell-derived plasma membrane vesicles to contain encapsulated IL-2 and engrafted costimulatory molecules for use in tumor immunotherapy
Research output: Contribution to journal › Article › peer-review
16Citations
(Scopus)
Fingerprint
Dive into the research topics of 'A novel approach for modifying tumor cell-derived plasma membrane vesicles to contain encapsulated IL-2 and engrafted costimulatory molecules for use in tumor immunotherapy'. Together they form a unique fingerprint.